Insider Transactions in Q3 2023 at Vor Biopharma Inc. (VOR)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2023
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
5,576
-3.97%
|
$11,152
$2.67 P/Share
|
|
Sep 01
2023
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
6,310
-4.13%
|
$12,620
$2.67 P/Share
|
|
Sep 01
2023
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,657
-1.82%
|
$25,314
$2.67 P/Share
|
|
Aug 07
2023
|
Nathan D. Jorgensen CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
834
-0.54%
|
$1,668
$2.67 P/Share
|
|
Aug 07
2023
|
Tirtha Chakraborty CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
875
-0.62%
|
$1,750
$2.67 P/Share
|
|
Aug 07
2023
|
Robert Ang PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,361
-0.34%
|
$4,722
$2.67 P/Share
|
|
Aug 07
2023
|
Eyal C. Attar CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-1.87%
|
$1,998
$2.67 P/Share
|